Literature DB >> 12956196

Pityriasis versicolor.

Aditya K Gupta1, Roma Batra, Robyn Bluhm, Jan Faergemann.   

Abstract

Pityriasis versicolor is a mild or chronic condition characterized by scaly hypopigmented or hyperpigmented lesions usually affecting the trunk. The lesions vary depending on tropical or temperate climates. The disease seems to occur mainly at adolescence when the sebaceous glands are more active. Malassezia yeasts have been implicated in the pathogenesis of this disease. The mycelial form of the fungus has been suggested to be the cause of lesions. Antifungal preparations have been used to treat the initial presentation effectively, although in a proportion of patients the disease tends to reoccur. They are available in a wide range of formulations and have been shown to be safe.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956196     DOI: 10.1016/s0733-8635(03)00039-1

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  11 in total

1.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

2.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

3.  Molecular epidemiology of Malassezia globosa and Malassezia restricta in Sudanese patients with pityriasis versicolor.

Authors:  M Saad; T Sugita; H Saeed; A Ahmed
Journal:  Mycopathologia       Date:  2012-10-04       Impact factor: 2.574

Review 4.  Bedside Diagnostics for Infections: A Guide for Dermatologists.

Authors:  Frank T Winsett; Shaunak G Patel; Brent C Kelly
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

5.  Atrophying pityriasis versicolor: is this a new variant of pityriasis versicolor?

Authors:  Yun-Seok Yang; Min-Kyung Shin; Choong-Rim Haw
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 6.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

7.  Uncommon presentations of tinea versicolor.

Authors:  Sowmya Varada; Tushar Dabade; Daniel S Loo
Journal:  Dermatol Pract Concept       Date:  2014-07-31

8.  Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial.

Authors:  Somenath Sarkar; Dipayan Sengupta; Sukumar Basak; Shabab Ahmed Damji; Devesh Kumar Shukla; Deep Anurag
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

9.  Pityriasis versicolor: a clinicomycological and epidemiological study from a tertiary care hospital.

Authors:  Sudip Kumar Ghosh; Sunil Kumar Dey; Indranil Saha; Jayasree Nath Barbhuiya; Arghyaprasun Ghosh; Aloke Kumar Roy
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 10.  Antifungal Treatment for Pityriasis Versicolor.

Authors:  Aditya K Gupta; Kelly A Foley
Journal:  J Fungi (Basel)       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.